1.
Blauvelt A, Pink A, Worm M, Langley R, Costanzo A, Gjerum L, Jorgensen E, Corriveau J, Guttman-Yassky E. COVID-19 in tralokinumab-treated patients with moderate-to- severe atopic dermatitis: case series from the ECZTEND long- term extension trial. J of Skin [Internet]. 2021Nov.5 [cited 2022Jul.5];5(6):s58. Available from: https://www.jofskin.org/index.php/skin/article/view/1409